Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E4QM | ISIN: US45259L2051 | Ticker-Symbol:
NASDAQ
06.06.25 | 21:41
0,460 US-Dollar
-7,82 % -0,039
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPACT BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
IMPACT BIOMEDICAL INC 5-Tage-Chart

Aktuelle News zur IMPACT BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.03.IMPACT BIOMEDICAL INC. - 8-K, Current Report2
21.03.Impact BioMedical-Aktien steigen bei unerklärlicher Marktaktivität 8
21.03.Impact BioMedical shares soar on unexplained market activity1
21.03.Impact BioMedical-Aktie schwankt ohne erkennbaren Grund-
21.03.Impact BioMedical shares fluctuate without clear cause1
IMPACT BIOMEDICAL Aktie jetzt für 0€ handeln
21.03.Impact Biomedical Inc. Announcement Stock Activity/Pricing224HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare...
► Artikel lesen
21.03.Pre-market Movers: Allurion Technologies, Impact BioMedical, Patriot National Bancorp, TransCode Therapeutics, DSS, Inc.641BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.10 A.M. ET).In the Green Allurion Technologies Inc. (ALUR) is up over 64% at...
► Artikel lesen
21.03.Why Impact Biomedical Inc. (IBO) Surged On Thursday?16
13.03.IMPACT BIOMEDICAL INC. - 8-K, Current Report5
26.02.Impact BioMedical acquires air purifier firm Celios2
26.02.Impact Biomedical Inc. Announces Acquisition of Celios, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"1
26.02.DSS, Inc. Announces Sale of Celios to Impact BioMedical, Streamlining Portfolio for Strategic Growth315ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air...
► Artikel lesen
29.01.IMPACT BIOMEDICAL INC. - 8-K, Current Report-
24.01.IMPACT BIOMEDICAL INC. - S-8, Securities to be offered to employees in employee benefit plans-
15.10.24Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker Technology Targeting Inflammatory Disease203HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker technology platform. The Canadian Intellectual...
► Artikel lesen
26.09.24Impact BioMedical, Inc.: Impact BioMedical Inc. (NYSE: IBO) Announces 3F US Patent Issue201HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. ("IBO") is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled "Insect Repelling...
► Artikel lesen
17.09.24Impact BioMedical, Inc.: Impact BioMedical Inc. Announces the Closing of its Initial Public Offering269NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the...
► Artikel lesen
16.09.24DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value243NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful...
► Artikel lesen
16.09.24Impact BioMedical Prices 1.5 Mln IPO At $3 Per Share617WASHINGTON (dpa-AFX) - Impact BioMedical Inc. (IBO), Monday announced the pricing of its initial public offering of 1.5 million shares at $3.00 per share. The offering is expected to close on...
► Artikel lesen
16.09.24Impact BioMedical, Inc.: Impact BioMedical Inc. Announces Pricing of Initial Public Offering259NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1